- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03805971
Probe Based Confocal Laser Endomicroscopy During Thoracoscopy for Pleural Malignancies Diagnosis.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Liège, Belgium, 4000
- CHU de Liège
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Every patient refered for a medical thoracoscopy and willing to participate.
Exclusion Criteria:
- < 18 ans
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
patient aged more than 18 years admitted for thoracoscopy
Probe based confocal laser endomicroscopy (Mauna kea technologies) will be used, after intravenous fluorescein injection, for every patients admitted for medical thoracoscopy, to study the pleural cavity.
Images will be compared with biopsies
|
Probe based confocal laser endomicroscope can be introduced through the working chanel of the thoracoscope.
this allows the study of the pleural cavity with this new tool.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pleural Carcinomatosis Identification (Compared to Standard Biopsies). Qualitative Criteria.
Time Frame: One day.
|
Eleven preselected criteria were assessed in their ability to distinguish benign from malignant pleura Qualitative variables are presented in this table
|
One day.
|
Pleural Carcinomatosis Identification (Compared to Standard Biopsies), Quantitative Criteria.
Time Frame: One day
|
Eleven preselected pCLE criteria were assessed in their ability to distinguish benign from malignant pleura. Here are presented Mean cell size and maximum vascular diameter |
One day
|
Pleural Carcinomatosis Identification (Compared to Standard Biopsies), Quantitative Criteria.
Time Frame: One day
|
Eleven preselected pCLE criteria were assessed in their ability to distinguish benign from malignant pleura. Quantitative criteria are presented in this table. Here is presented the mean cellular density |
One day
|
Pleural Carcinomatosis Identification (Compared to Standard Biopsies), Quantitative Criteria.
Time Frame: One day
|
Eleven preselected pCLE criteria were assessed in their ability to distinguish benign from malignant pleura. Quantitative criteria are presented in this table. Here is presented the vascular density. |
One day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Quality of the pCLE Acquisition
Time Frame: One day
|
The investigators performing the thoracoscopy had to score the pCLE acquisition.
Three level of quality were used: Good, Acceptable, Low.
|
One day
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Olivier Bonhomme, MD, CHU de Liège
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- B707201837069
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pleural Carcinomatosis
-
Hospices Civils de LyonRecruiting
-
Institut du Cancer de Montpellier - Val d'AurelleRecruitingPeritoneal Carcinomatosis | Peritoneal MesotheliomaFrance
-
Hospices Civils de LyonWithdrawn
-
Association Francaise de ChirurgieCompletedCarcinomatosis, PeritonealFrance
-
Hasselt UniversityZiekenhuis Oost-LimburgUnknownColorectal Peritoneal CarcinomatosisBelgium
-
University of California, IrvineRecruitingPeritoneal Carcinomatosis | Gastrointestinal Peritoneal CarcinomatosisUnited States
-
Hospices Civils de LyonUnknownColorectal Peritoneal CarcinomatosisFrance
-
Jules Bordet InstituteCompletedColorectal CarcinomatosisBelgium
-
Gustave Roussy, Cancer Campus, Grand ParisTerminatedPatients With Gastric Peritoneal CarcinomatosisFrance
-
Uppsala UniversityCompletedColorectal Peritoneal CarcinomatosisSweden
Clinical Trials on Study of the pleural cavity with a confocal laser endomicroscope.
-
Centre Hospitalier Universitaire de NīmesRecruiting
-
Campus Bio-Medico UniversityPolitecnico di MilanoRecruitingPancreatic NeoplasmsItaly
-
Seoul National University HospitalCompletedBiological DressingsKorea, Republic of
-
Hospices Civils de LyonCompletedModerate to Severe Hearing Loss | Indication of Middle Ear Implant (MET)
-
I.M. Sechenov First Moscow State Medical UniversityRecruitingAnterior Cruciate Ligament Injuries | Hallux RigidusRussian Federation
-
Samara State Medical UniversityRecruitingEndothelial Dysfunction | Cardiotoxicity | Acute Myeloid Leukemia, AdultRussian Federation
-
Zonguldak Bulent Ecevit UniversityActive, not recruitingPain After AdenotonsillectomyTurkey
-
Universitaire Ziekenhuizen KU LeuvenUniversity of Pittsburgh; Sheba Medical Center; Mount Sinai Hospital, Canada; Leiden... and other collaboratorsUnknownTwin Reversal Arterial Perfusion SyndromeSpain, Germany, Israel, Belgium, Netherlands, Canada, United States, Austria, France, Italy, United Kingdom
-
Istituto Clinico HumanitasUnknown
-
Memorial Sloan Kettering Cancer CenterPfizer; Dana-Farber Cancer Institute; University of Pittsburgh; University of VirginiaCompletedNeurofibromatosis | Meningioma | CNS Cancer | Hemangioblastoma | Intracranial HemangiopericytomaUnited States